Donor explorer

HCC_GSE140228_Cell_2019

Dataset-level donor/sample index migrated from ImmuneAging into LACA. Open a donor ID to inspect de-identified metadata, source notes, and UMAP preview status.

Browse donors Back to atlas

CIMA_PBMC_Science_2025 COVID19_PBMC Neutrophil_LiverCancer_Nature_2022 SCAR244 HCC_GSE140228_Cell_2019 Thymus_PBMC_NatureAging_2025 CancerSCEM 2.0 LGH_Immunity Fetus_PBMC_Cell_2025 GSE243013_NSCLC_anti_PD1 GSE279452_Sepsis_PBMC GSE134355_Human_Cell_Landscape_HCL GSE316337_Type1_Diabetes_PBMC GSE254249_Rectal_Cancer_TNT GSE206785_Gastric_Cancer_TME GSE182159_HBV_Liver_Blood_Immune GSE189955_HGSC_Multiomics GSE149938_Human_Blood_Cell_Atlas GSE207422_NSCLC_PD1_Chemo GSE221521 GSE255685 GSE182409 Han Chinese serum proteome pQTL / GNHS + WEBIRTH CRC plasma proteomics, Zhejiang discovery cohort RA serum proteomics, Guangzhou MTBLS13155 MTBLS352 MTBLS11996 MTBLS12968 MTBLS12820 MTBLS13501 MTBLS9664 MTBLS5568 Bian_PBMC_NI_2025 LGH_X_Age

PopulationChinese HCC cohort

ModalityscRNA-seq (10x droplet + Smart-seq2)

DataAvailable; Virtual donor UMAP shown until embedding export

Donor Table

10 rows in this dataset; 50 rows per page.

						Details
D20170222	D20170222-Blood-CD45+, D20170222-Normal-CD45+, D20170222-Tumor-CD45+	49 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage IIIA	blood; adjacent liver tissue; tumor tissue	UMAP + Gene
D20170227	D20170227-Blood-CD45+, D20170227-Tumor-CD45+	84 years	Female	Hepatocellular carcinoma (HCC); HBV -; tumor stage IIIA	blood; tumor tissue	UMAP + Gene
D20170322	D20170322-Blood-CD45+, D20170322-Blood-CD45+CD3+, D20170322-Normal-CD45+, D20170322-Normal-CD45+CD3+, D20170322-Tumor-CD45+, D20170322-Tumor-CD45+CD3+	32 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage I	blood; adjacent liver tissue; tumor tissue	UMAP + Gene
D20170327	D20170327-Blood-CD45+, D20170327-Blood-CD45+CD3+, D20170327-Normal-CD45+, D20170327-Normal-CD45+CD3+, D20170327-Tumor-CD45+, D20170327-Tumor-CD45+CD3+	57 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage IIIA	blood; adjacent liver tissue; tumor tissue	UMAP + Gene
D20170412	D20170412-Blood-CD45+, D20170412-Blood-CD45+CD3+, D20170412-Normal-CD45+, D20170412-Normal-CD45+CD3+, D20170412-Tumor-CD45+, D20170412-Tumor-CD45+CD3+	60 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage IIIA	blood; adjacent liver tissue; tumor tissue	UMAP + Gene
D20171109	D20171109-Ascites-CD45+, D20171109-Ascites-CD45+CD3+, D20171109-Blood-CD45+, D20171109-Blood-CD45+CD3+, D20171109-Lymphnode-CD45+, D20171109-Lymphnode-CD45+CD3+, D20171109-Normal-CD45+, D20171109-Normal-CD45+CD3+, D20171109-Tumor-CD45+, D20171109-Tumor-CD45+CD3+, D20171109_A, D20171109_B, D20171109_LN, D20171109_Nplus, D20171109_Tplus	54 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage II	ascites; blood; hepatic lymph node; adjacent liver tissue; tumor tissue	UMAP + Gene
D20171215	D20171215_A, D20171215_B, D20171215_LN, D20171215_N, D20171215_T	47 years	Male	Cholangiocarcinoma (CC); HBV -; tumor stage II	ascites; blood; hepatic lymph node; adjacent liver tissue; tumor tissue	UMAP + Gene
D20180108	D20180108_B, D20180108_N, D20180108_T, D20180108_TC	68 years	Male	Hepatocellular carcinoma (HCC); HBV -; tumor stage II	blood; adjacent liver tissue; tumor tissue	UMAP + Gene
D20180110	D20180110_A, D20180110_N, D20180110_T, D20180110_TC	69 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage II	ascites; adjacent liver tissue; tumor tissue	UMAP + Gene
D20180116	D20180116_A, D20180116_LN, D20180116_N, D20180116_T, D20180116_TC	62 years	Male	Hepatocellular carcinoma (HCC); HBV +; tumor stage II	ascites; hepatic lymph node; adjacent liver tissue; tumor tissue	UMAP + Gene